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A B S T R A C T   
Highly polar ethanolamines (EAs), excreted in urine, are hydrolysis products of nitrogen mustards (NMs), which 
are prohibited by the Chemical Weapons Convention (CWC). The methods established for biological matrices are 
essential for verification analysis of the CWC related chemicals. This paper describes a new liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) method developed for qualitative and quantitative 
analysis of EAs, N-ethyldiethanolamine (EDEA), N-methyldiethanolamine (MDEA) and triethanolamine (TEAOH) 
from urine samples. After optimization of sample preparation and chromatographic conditions, the method was 
fully validated. Silica solid-phase extraction (SPE) cartridges and a porous graphite carbon (PGC) column were 
selected for validation studies. The method is linear from 5 to 500, 0.5 to 250, and 0.5 to 500 ng/mL for TEAOH, 
EDEA, and MDEA, respectively. It is also precise and accurate. A minimum sample amount of 0.5 mL urine was 
used. The limit of quantification using this approach was 0.4, 5.5, and 6.3 ng/mL for MDEA, EDEA and TEAOH, 
respectively. The combination of the PGC column and high pH eluents in analysis retained and separated the 
studied EAs. Retention times were 2.11, 2.56 and 2.98 min for MDEA, EDEA and TEAOH, respectively. The 
method is applicable for verification analysis of the CWC.   
1. Introduction 
Nitrogen mustards (NMs) are alkylating agents and classified as toxic 
chemicals in Schedule 1 in the Chemical Weapons Convention (CWC) 
[1]. NMs include bis(2-chloroethyl)ethylamine (HN1), bis(2- 
chloroethyl)methylamine (HN2), and tris(2-chloroethyl)amine (HN3). 
The use of NMs as chemical weapons (CWs) has not been documented, 
even though they could be used in chemical terrorism. This might be 
because of their short lifetime as they become unstable after long-term 
storage of one to three months [2]. In view of the low persistency in 
the environment, biomedical would be an important source of evidence 
for the investigation of alleged use of these CWs. Thus, the development 
of methods for detecting CWs in biomedical samples would provide 
qualitative and quantitative evidence of CWAs exposure. The Organi-
zation for the Prohibition of Chemical Weapons (OPCW), CWC imple-
menting agency, will send authentic samples collected by OPCW 
inspectors to designated laboratories (DLs) to examine the use of any 
prohibited chemicals. There is a need to develop highly selective and 
sensitive methods to detect these chemicals in different matrices with a 
limited sample at low concentration. A method that can be used in a 
great variety of situations is preferable. 
The NMs decompose to ethanolamines (EAs) via hydrolysis between 
carbon atoms and a leaving group (Cl) [3]. N-ethyldiethanolamine 
(EDEA), N-methyldiethanolamine (MDEA) and triethanolamine 
(TEAOH) are hydrolysis products of HN1, HN2 and HN3, respectively 
[4]. Their molecule structures and their pKa values are given in Fig. 1. 
TEAOH, which is widely used in industrial and domestic cleaning 
products and cosmetics, can be endogenous in high concentrations in 
human urine [5]. Consequently, other biomarkers are needed to confirm 
exposure to HN3. 
Several papers have reported a variety of analytical techniques for 
EA analysis such as capillary electrophoresis (CE) [6], gas 
chromatography-electron impact/mass spectrometry (GC-EI/MS) 
[7–11], liquid chromatography-tandem mass spectrometry (LC-MS/MS) 
[12–17], and matrix-assisted laser desorption ionization time-of-flight 
mass spectrometry (MALDI-TOFMS) [18]. Tandem mass spectrometry 
offers better sensitivity and selectivity than single-stage MS. Detection 
limits ranged from parts per million (ppm) to as low as parts per billion 
(ppb). 
Various sample preparation involving solid-phase extraction (SPE) 
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[7,12,13,17,19–22], derivatisation [9–11,14,15], and solvent extraction 
[17] are used for detection of EAs in different matrices like urine 
[10,11,19,21,22], water [7,11,14,17], decontamination solution [17], 
plasma [7,23], and serum [23]. Different types of SPE sorbents have 
been applied, namely strong cation exchange (SCX) [7,22,24], and non- 
polar (C18) [13] sorbent depending on the studied matrices for EA 
analysis. NMs themselves have also been extracted using a silica SPE 
cartridge and acetone as an extraction solvent [20]. 
Several derivatizing agents have been used for GC–MS analysis of 
EAs such as 1-(heptafluorobutyryl)imidazole for aqueous samples [14], 
tert-butyldimethylsilyl (TBDMS) for water, urine and blood samples 
[11]. Derivatization steps sometimes contribute to low recoveries, and 
they are time-consuming since concentration to dryness as part of 
sample treatment is required. It can also be a significant error source 
when extraneous materials react with the derivatizing agent to produce 
a complex background [9]. To overcome these issues, LC-MS has been 
used to analyse EAs during recent years [25]. 
Most of the research on bioanalytical methods for NMs and EAs have 
been done from the blood (whole, plasma, serum) and urine samples. 
These are the most available samples that accumulate a high proportion 
of the dose in surviving casualties [24]. Excretion via urine is a main 
route of elimination. However, it has the disadvantage that the major 
portion (~90%) of the metabolites formed are excreted within the first 
72 h after exposure. Numerous methods for the detection of EAs in urine 
have been developed [10,19,21,22]. Most of the published methods for 
urine samples use SCX sorbents and separate the EAs chromatographi-
cally using hydrophilic interaction chromatography (HILIC) and LC-MS/ 
MS [19,22]. Another method uses ACN for extraction of water samples 
and a mixed-mode ultra high performance liquid chromatography 
(UHPLC) column with embedded ion-pairing groups (exhibiting both 
hydrophobic and cation exchange retention mechanisms) for chro-
matographic separation [17]. There are also established methods to 
detect the exposure of NMs in blood matrices [13,23,26]. These methods 
via DNA and protein adducts are preferable because NM adducts to 
proteins such as albumin and haemoglobin are ideal as they are stable 
for several weeks to months [23]. 
This paper focuses on NM hydrolysis products in urine samples. Also, 
this study aimed to develop an analytical method for extracting these 
highly polar compounds from a urine sample while at the same time 
simplifying the sample preparation procedure and reducing the sample 
volume in use. Several SPE sorbents and LC columns were tested, and a 
method using silica SPE and porous graphitic carbon (PGC) was opti-
mized and validated for analysis of EAs from urine samples. The use of 
silica SPE sorbent combined with PGC column was highly effective for 
retaining EAs and reduced urine sample background. To our knowledge, 
this is the first-time a combination of high pH mobile phase and a PGC 
column was used to separate highly polar analytes. 
2. Material and methods 
2.1. Materials and reagents 
Reference chemicals of EDEA and MDEA were synthesized at VER-
IFIN, and TEAOH was obtained from Sigma Aldrich (St. Louis, MO, 
USA). NMR was used to determine the concentrations of stock solutions 
of reference chemicals, and the purity of the stocks ranged from 69% to 
88%. D15-TEAOH was obtained from CDN Isotopes (Essex, UK). This 
compound was found to be D12-TEAOH after purity check by NMR and 
LC-MS/MS. The stock solutions were prepared by dissolving the analytes 
in ACN and stored at 4 ◦C. The working solution was prepared for the 
appropriate concentration by diluting with purified water before use. 
A few types of SPE cartridges and LC columns were tested in this 
study as shown in Table 1. Methanol (MeOH) and ACN were obtained 
from Honeywell Fluka (Loughborough, LE, UK) and JT Baker (Phillips-
burg, NJ, USA), respectively. Other chemicals and reagents such as 
ammonium acetate (NH4OAc) and ammonium formate (NH4HCO2) 
were purchased from Sigma Aldrich (St. Louis, MO, USA), formic acid 
for LC-MS (98–100%) from Merck (Darmstadt, Germany) and ammo-
nium hydroxide solution (NH4OH, ≥25% in H2O), eluent additive for 
LC-MS grade from Honeywell Fluka (Seelze, Germany). All chemicals 
and reagents were of analytical grades or higher. The water used in this 
study was purified using a Direct-Q3 UV system (Millipore, Germany). A 
pooled human urine was provided from six healthy volunteers (three 
males and three females). 
2.2. LC-MS/MS 
LC was performed by Waters Acquity UPLC i-Class from Waters 
Corporation (Milford, MA, USA). This UHPLC system was coupled to a 
Waters Xevo TQD triple quadrupole mass spectrometer from Waters 
Corporation (Milford, MA, USA). A PGC column was used as the sta-
tionary phase at 40 ◦C. Solvent A (5 mM NH4OAc, pH 11.0) and solvent 
B (5 mM NH4OAc in MeOH, pH 11.0) were used as mobile phase in the 
validation studies. Masslynx (version 4.1) was applied for utilizing data 
acquisition and quantitative analysis. 
The optimized chromatographic conditions consisted of initial con-
ditions of 1% B gradually increased to 100% B in 5 min. It was then held 
for 1 min before the B ratio was decreased to 1% B in 0.3 min, and the 
column was equilibrated for 1.2 min at 1% B. The flow rate was 0.4 mL/ 
min, and the injection volume was 5 µL. 
The acquisition was performed in multiple reaction monitoring 
(MRM) mode after positive electrospray ionization (ESI) with nitrogen 
(N2) as the spray gas and argon (Ar2) as the collision gas. The instrument 
parameters were set as follows: capillary voltage 500 V, cone voltage 32 
V, source temperature 150 ◦C, desolvation temperature 500 ◦C, cone gas 
flow 160 L/hr, desolvation gas flow 1000 L/hr and collision gas flow 
150 mL/min. 
2.3. Sample preparation 
A mixed standard solution of EAs and internal standard (ISTD, D12- 
TEAOH) were prepared in purified water. An appropriate amount of 
mixed standard solution of EAs was spiked into 0.5 mL of blank urine 
samples to prepare a calibration curve ranging from 5 to 500 ng/mL for 
TEAOH, 5 to 250 ng/mL for EDEA, 0.5 to 500 ng/mL for MDEA and QC 
sample (25 ng/mL). 50 µL of ISTD (250 ng/mL) was added to all samples 
to give a final concentration of 25 ng/mL. The spiked samples (cali-
bration standards and QC samples) were mixed for 10 s on a vortex 
mixer and left at room temperature for at least 1 h before SPE clean up. 
Fig. 1. Chemical structures and pKa values of EAs (accessed from Pubchem).  
Table 1 
SPE cartridges and LC columns tested in this study.  
SPE cartridges LC columns 
Bond Elut Jr strong cation exchange 
(SCX), 500 mg/ 6 mL), 40 µm, Agilent 
(Wilmington, DE, USA) 
ACQUITY UPLC BEH C18 column, 2.1 ×
100 mm, 1.7 μm, Waters (Milford, MA, 
USA) 
Strata® SI-1 Silica (55 µm, 70 A), 500 
mg/ 6 mL), Phenomenex (Torrance, 
CA, USA) 
BEH Amide column, 2.1 × 100 mm, 1.7 
μm, Waters (Milford, MA, USA) 
HyperSep™ Hypercarb™ SPE 
Cartridges, 200 mg/3mL, 30 µm, 
Thermo Scientific (San Jose, USA) 
Porous graphitic carbon (PGC) 
Hypercarb™, 2.1 × 100 mm, 3.0 μm, 
Thermo Scientific™ (San Jose, USA)  
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SPE protocols such as sample dilution, conditioning, washing, and 
eluting solvents were established for this study. The pH of the urine 
sample was measured before analysis. It was then basified to approxi-
mately pH 11.0 using 0.2 M NH4OH before following the SPE protocols 
mentioned below. For sample dilution, 5 mL of water was added into 0.5 
mL of a urine sample and vortexed for 10 s before loaded into the SPE 
cartridge. ACN (2 × 3 mL) was used for pre-conditioning the silica SPE 
cartridges. Then, a total of 5.5 mL of a diluted urine sample was loaded 
on the pre-conditioned cartridge. The cartridge was washed with ACN 
(2 × 3 mL). 75% methanol (MeOH) containing 1% formic acid (2 × 3 
mL) was used for eluting the EAs from the SPE cartridge. The eluate was 
concentrated to dryness under a gentle stream of nitrogen in a Turbo-
Vap® LV II (Caliper Life Sciences, Hopkinton, MA, USA) at 45 ◦C and 7.5 
psi. Finally, the residue was dissolved in 400 µL of 5 mM NH4OAc, pH 
11.0 (mobile phase A) before LC-MS/MS analysis. 
3. Results and discussion 
3.1. Optimization of LC-MS/MS parameters 
Initially, when the reversed-phase C18 column was tested, the EAs 
were not retained well on the column because of their hydrophilic na-
ture. Therefore, a BEH Amide (HILIC column) was tested to separate the 
three hydrolysis products. The HILIC column showed high intensity and 
symmetry of peaks for all analytes, but the analytes were not well 
separated. Despite trying several gradient profiles and buffer composi-
tions, sufficient separation of analytes was not achieved using the HILIC 
column. Carryover was also observed mainly for MDEA transitions. 
Various washing solvents for injector were also tested; however, it did 
not resolve the carryover problem. 
Eventually, a PGC column was selected because of its ability to retain 
very polar compounds and separate closely related compounds. This 
column is also stable throughout the entire pH range of 1 to 14, and it is 
proven to withstand aggressive mobile phases. It also worked well to 
resolve EAs. The retention of EAs in the PGC column is based on the 
mechanism of charge induced interactions of these highly polar analytes 
with the polarizable surface of graphite and delocalized electrons on the 
graphite surface. This graphite behaves both as an electron donor and 
electron acceptor. 
There were also no significant differences for changing the column 
temperature from 40 ◦C to 60 ◦C (data not shown). 
The PGC chromatographic system was first tested under acidic con-
ditions (0.1% formic acid in 5 mM NH4HCO2/ACN). When the studied 
EAs were analysed under this condition, the peaks eluted early with 
suboptimal peak shape and analyte resolution (data not shown). Next, a 
basic eluent system (5 mM NH4OAc in water/MeOH) was tested (pH 
8.4). The separation was sufficient and showed better peak shapes. Both 
eluent systems were evaluated using isocratic and gradient modes. For 
Fig. 2. A comparison of different pH of LC eluents (5 mM of NH4OAc in water/MeOH) for 10 ng/mL of reference standard EAs.  
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isocratic mode, the peaks only separated when a higher aqueous 
composition was used; however, the isocratic method showed broader 
peak shapes. Later, gradient mode was applied to optimize the retention 
and the peaks shape of EAs. Fig. 2 shows the tested eluent pH conditions, 
ranging from 5.5 to 12.0, and evaluated using gradient mode. 
For the validation studies, an eluent system with a higher pH (pH 
11.0) was chosen instead of pH 9.5 because it showed a lower back-
ground, especially for EDEA transitions. The basic eluent at pH 12.0 was 
not selected because it is too close to the UHPLC system’s maximum pH 
operating capacity (pH 12.5). Eluents with a higher pH (pH 11) likely 
gave the best chromatographic separation because, under these condi-
tions, the EAs exist as free bases. 
The LC-MS/MS method was optimized using reference standards of 
the studied chemicals at a 10 ng/mL concentration level. Protonated 
molecules were used as the precursor ions. Collision energies for all 
product ions after optimization were 15 eV. The mass transitions are 
presented in Table 2. 
3.2. Optimization of sample preparation 
3.2.1. Recoveries in different SPE cartridges 
Three replicates of EAs for each studied SPE cartridges (silica, PGC 
and SCX) were used to determine the recoveries for the SPE cartridge 
extraction studies. The analytical results of extracted samples (n = 3) 
were compared with corresponding extracts of blanks spiked with the 
analyte (n = 1) post-extraction. Both extracted and unextracted (post- 
extraction) were prepared in a blank urine matrix, and the concentration 
of EAs was 100 ng/mL. The EAs were spiked in a blank urine matrix for 
the extracted sample replicates before following the SPE protocols 
mentioned in Section 2.3. For the unextracted QC, the EAs was spiked 
into eluate (blank urine matrix undergo SPE extraction) before the 
drying process. The percent recovery was calculated based on Equation 
S1. The recoveries of extraction methods using these three different SPE 
cartridges for EAs in urine samples are shown in Fig. 3. Based on the 
results, this extraction method using silica SPE cartridges was found to 
offer optimal recoveries for all three EAs. Primarily, SCX SPE cartridges 
were tested. While the degrees of recovery were acceptable, high matrix 
interference and increased background were observed for EDEA and 
MDEA transitions (data not shown), even though the analysis was car-
ried out as described in a previously published method [19]. Sodium 
(Na) ion or any other intrinsic ions in urine samples may have contrib-
uted to the matrix effects, causing ion suppression when insufficiently 
removed by the SCX cartridges. 
Subsequently, normal phase silica SPE cartridges were tested 
because of their ability to extract polar analytes. According to Recom-
mended Operating Procedures (ROPs) [27], SPE using silica cartridges 
and ACN extraction is the most common method used to extract CWAs 
from organic samples. ACN was chosen to extract EAs from urine sample 
because of its capability to disrupt the H-bond between EAs with the 
“–OH” group present on the silica surface. 
A PGC-based SPE cartridge (HyperSep™ Hypercarb™ SPE Car-
tridges) was also tested based on the same chemistry used in the PGC LC 
column. The same conditions and procedures used in Silica SPE car-
tridge were applied to this PGC SPE cartridge. Unfortunately, the PGC 
cartridges showed low recovery for the EAs from urine samples. The SPE 
protocol may need more extensive optimisation for sufficient recovery 
and clean up of urine samples. 
Extracted ion chromatograms (EIC) of reference chemicals of EAs, 
blank urine and spiked urine cleaned up by Silica SPE cartridge are given 
in Fig. 4. The concentration of EAs for both reference chemicals and 
spiked urine was 25 ng/mL. The final concentration of ISTD in all urine 
samples was 25 ng/mL. The reference chemicals (A) were prepared by 
spiking mixed standard solution of EAs and ISTD into eluate before the 
drying process. The blank urine (B) was prepared by adding 50 µL of 
ISTD (250 ng/mL) and 50 µL of purified water into a urine sample. For 
spiked urine (C) and blank urine, the ISTD or mixed standard solution of 
EAs were spiked before SPE procedures. The reconstituted samples were 
analysed via LC-MS/MS. 
3.2.2. Matrix interferences 
There is no contribution for TEAOH signal from the D12-TEAOH. In 
blank urine, a TEAOH signal was present at five times weaker concen-
tration compared to the 25 ng/ml spiked standard (Fig. 4). Since TEAOH 
is ubiquitously used in cleaning products and cosmetics, it can typically 
also be found in human urine without exposure to NMs [5]. There was 
also interference in EDEA transitions; however, it only appeared at m/z 
116 transitions (third product ion). This transition is eluted at a different 
RT than that of the EDEA transition peaks (EDEA RT = 2.92); therefore 
this transition was omitted for the validation analysis. For MDEA tran-
sitions, there was also interference seen from urine background, which 
eluted at 2.24 mins, 0.2 min after MDEA peaks (MDEA RT = 1.99). This 
interference was intense at the m/z 102 transition, and it was the reason 
m/z 58 and 45 were chosen as quantifier and qualifier ions for this 
chemical. The integration process should be done precisely and consis-
tently, particularly at a low concentration level. The effect of pH on the 
urine samples was also studied. Silica SPE cartridge was used in this 
study. Urine samples were adjusted to lower pH (acidified) using 0.1% 
formic acid and higher pH (basified) using 0.2 M NH4OH. The recoveries 
of EAs increased when urine samples were treated using higher pH, as 
shown in Supplementary Material (Table S1). The recoveries for basified 
urine were 32%, 97% and 99.5% for TEAOH, EDEA and MDEA, 
respectively. 
3.2.3. Optimisation of the SPE procedures 
Initially, 1 mL of urine was used in method development according to 
previously published methods [19,22]. However, when the volume was 
decreased by half (0.5 mL), it showed the same peak intensity as in 
higher volume (1 mL). A reduced sample volume for the final sample 
preparation is a significant improvement. ACN and water were also 
tested as a dilution solvent to dilute urine samples. Water was chosen 
Table 2 
Mass Spectrometric parameters.  
Analyte [M+H]+ product ion, m/z 
EDEA 134 72 (Q), 88 (q), 116 
MDEA 120 58 (Q), 45 (q), 102 
TEAOH 150 70 (Q), 132 (q), 88 
D12-TEAOH 162 58 (Q), 96 (q) 
Q quantifier ion and q qualifier ion  
Fig. 3. The recoveries of the extraction methods for three types of SPE car-
tridges (n = 3). The concentration of EAs in spiked urine was 100 ng/mL. EAs 
were chromatographically separated by a PGC column using optimized gradient 
mode in basic LC eluent (5 mM of NH4OAc in water/MeOH; pH 11). 
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because it gave higher recoveries for EDEA and MDEA from the urine 
sample. The details of the study of the dilution solvent and corre-
sponding recoveries are stated in Supplementary Material (Table S2). 
ACN was also evaluated to pre-conditioning of the silica SPE sorbent 
instead of methanol due to its nucleophilic nature. A higher ACN con-
centration is required to allow interaction of the compounds with the 
silica sorbent [27]. ACN was also used as a washing solvent. In this 
study, ACN effectively improved EAs recoveries from the urine sample, 
as demonstrated in Supplementary Material (Table S3). 
Next, MeOH was chosen as an elution solvent because it was miscible 
with the loading and washing solvents. It also has a higher elution ca-
pacity than ACN to elute EAs from the silica SPE cartridges. Four 
different MeOH mixtures, namely 50%, 75%, 1% formic acid in 50% 
MeOH and 1% formic acid in 75% MeOH were prepared and tested to 
optimize the elution solvent. The mixture of 1% formic acid in 75% 
MeOH gave higher recoveries compared to others. The addition of for-
mic acid substantially enhanced the EAs recoveries. The more organic 
solvent in the elution mixture also shortened the drying process. The 
details of the study of elution solvents and corresponding recoveries are 
shown in Supplementary Material (Table S4). 
3.3. Method validation 
This method was validated and included all the performance criteria 
needed, such as linearity, selectivity, accuracy, sensitivity precision, and 
recovery. The validation was performed in three days. Three calibration 
curves were obtained per day (n = 9), and the standards were made by 
spiking into pooled blank urine that had undergone SPE-treatment. True 
values for the concentrations of calibration standards and their accuracy 
(relative standard deviation, RSD) were calculated from nine calibration 
curves. Single-factor ANOVA (Analysis of Variance) was used to deter-
mine the precision (variance within groups and between groups), 
random error, systematic error (bias), and uncertainty estimation from 
the calibration standards’ true values. The validation results are shown 
in Table 3. 
For linearity studies, nine-point calibration standards ranging from 
0.5 to 500 ng/mL were prepared in a blank urine matrix. Calibration 
curves were established for all analytes by plotting the response against 
Fig. 4. EIC of EAs in urine extracted by Silica SPE cartridge. The concentration of EAs for reference chemicals (A) and spiked urine (C) was 25 ng/mL. Only ISTD was 
spiked in blank urine (B). The analytes were chromatographically separated by PGC column using optimized gradient mode in basic LC eluent (5 mM of NH4OAc in 
water/MeOH; pH 11). 
Table 3 
The calculated validation results for EAs.  




















TEAOH 5 3.6 0.6 16.7 0.5 0.5 13.1 − 37.0 ±19.5  
10 8.7 1.3 15.3 1.3 0.7 9.6 − 14.7 ±16.8  
25 24.1 1.7 7.1 2.0 1.0 1.9 − 3.7 ±9.3  
50 50.3 3.0 5.9 2.6 2.0 4.1 0.6 ±6.6  
100 101.8 4.0 4.0 3.0 3.5 3.1 1.8 ±4.6  
250 253.4 5.5 2.2 5.1 3.4 1.4 1.3 ±3.0  
500 498.0 2.3 0.5 2.1 1.4 0.3 − 0.4 ±1.1 
EDEA 5 4.8 0.3 5.9 0.3 0.2 3.9 − 3.1 ±6.5  
10 10.0 0.5 4.9 0.5 0.2 3.0 − 0.1 ±5.3  
25 25.7 0.9 3.5 0.8 0.2 2.5 2.8 ±4.0  
50 50.8 2.7 5.4 3.2 1.7 1.3 1.6 ±7.2  
100 99.5 2.7 5.4 1.7 0.8 0.5 − 0.6 ±1.9  
250 232.0 16.9 7.3 16.5 8.0 4.4 − 7.7 ±12.0 
MDEA 0.5 0.6 0.1 15.8 0.1 0.1 10.7 18.3 ±24.6  
1 1.0 0.1 10.1 0.1 0.1 6.4 − 0.8 ±12.8  
5 4.7 0.1 2.3 0.1 0.0 0.9 − 6.9 ±2.8  
10 9.3 0.4 4.4 0.4 0.1 2.5 − 7.9 ±4.8  
25 25.2 0.9 3.4 0.6 0.8 2.7 0.9 ±3.9  
50 50.7 2.1 4.2 2.4 1.0 1.6 1.4 ±5.2  
100 104.1 4.5 4.3 5.2 2.3 1.5 4.0 ±5.8  
250 250.9 6.7 2.7 7.1 1.0 1.3 0.4 ±2.9  
500 469.6 17.4 3.7 10.2 16.8 3.1 − 5.4 ±13.5  
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the expected calibrator concentration. A none weighted linear regres-
sion was performed for TEAOH and EDEA, and 1/x2 for MDEA. The 
calibration curve for TEAOH using D12-TEAOH as ISTD with the nine 
points per level are presented in Fig. 5. An average R2 for TEAOH from 5 
to 500 ng/mL was 0.9999. Even though the entire range of 0.5 to 500 
ng/mL was linear for TEAOH, the calibration curves were evaluated 
from 5 ng/mL as its limit of quantitation (LOQ) was 6.3 ng/mL. For 
EDEA, the curves were linear from 0.5 to 250 ng/mL and an average R2 
= 0.9992. For MDEA, the curves also linear for the entire range from 0.5 
to 500 ng/mL with an average R2 = 0.9902. Average calibration curves 
for EDEA and MDEA are presented in Supplementary Material (Figs. S1 
and S2). Quality control samples (25 ng/mL) were analysed after every 
calibration standard run to establish the LC-MS instrument’s 
performances. 
The selectivity of the method was examined during validation with a 
blank urine matrix and purified water. There are some interferences 
observed for TEAOH in the blank samples as they present in relatively 
high amounts in human urine [5] due to its use in industrial and do-
mestic cleaning products and cosmetics. Additionally, TEAOH was 
observed in the LC eluents when a lower-grade NH4OH was used. This 
signal was reduced to lower than the LOQ after using higher grade 
NH4OH. The use of D12-TEAOH compensated for the effects of this 
interference. Two transitions in multiple reaction monitoring (MRM) 
modes were used for each analyte, as presented in Table 2. For TEAOH, 
the response was calculated from the standard areas divided by the ISTD 
areas. The EDEA and MDEA responses were obtained from the ratio 
between qualifier and quantifier ions. The average of q/Q ratio for EDEA 
and MDEA was 17% and 36%, respectively. According to the European 
Union (EU) criteria for the mass spectrometric techniques [28], the 
maximum permitted tolerance for relative ion intensities for EDEA is 
±30%, and MDEA is ±25%. It gives the maximum tolerance of ±5 and 
±9 for EDEA and MDEA, respectively. The average retention time for 
TEAOH was 2.56, with RSD 0.3%. For EDEA and MDEA, the retention 
time was 2.98 and 2.11 with RSD 0.8% and 0.4%, respectively. 
The accuracy was determined for each chemical at all studied con-
centration levels. We followed the Food and Drug Administration (FDA) 
bioanalytical method validation recommendations that the values need 
to be within 15% at nominal concentration and less than 20% at the LOQ 
[29]. These values also applied to precision studies. For TEAOH, all the 
RSD values obtained were under 15% except for the lowest concentra-
tion level, which it was 16.7%. All RSD values are below than 7.3% for 
EDEA. For MDEA, all the RSD values were within the FDA recommen-
dations (Table 3). 
The precision of the method was assessed using variance within 
group and between groups. For TEAOH, the variance within groups and 
between group was under 5.1%. The variances value was also acceptable 
for EDEA except at the highest concentration level (RSD = 16.5%). The 
values acquired for MDEA were under the limit except for the variance 
between group at the highest concentration level. Most of the values 
obtained follow FDA guidelines. 
The method sensitivity was defined by the limit of detection (LOD) 
and the LOQ. It was determined from the linear regression from equa-
tions (1) and (2), where s is the standard deviation of the signal (y- 
intercept) and b is the slope of the nine calibration curves prepared in 
blank urine matrix. Measured LODs were 0.1, 1.7, and 1.9 ng/mL for 
MDEA, EDEA, and TEAOH, respectively. LOQs for all chemicals are 
shown in Table 4. 








The within run precision was established using six replicates (n = 6) 
of spiked samples at four different concentration levels of 5, 25, 100 and 
250 ng/mL. The method is precise, and the results obtained are pre-
sented in Supplementary Material (Table S5). The highest relative 
standard deviation (RSD, %) for TEAOH was 6.8% at 5 ng/mL, and the 
lowest was 2.1% at concentration level 100 ng/mL. For EDEA, the RSD 
ranged from 2.3% to 8.4% at 25 and 250 ng/mL, respectively. Compared 
to the other two EAs, MDEA achieved the lowest RSD with just 0.7% at 
25 ng/mL. All the RSD obtained during the precision study also com-
plied with the FDA guidelines [29]. 
The method’s recovery was evaluated by spiking three (n = 3) par-
allel samples at three different concentration levels of 5, 50 and 250 ng/ 
mL. The results are presented in Table 5. The analytical results of 
extracted samples were compared with corresponding extracts of blanks 
spiked with the analyte post-extraction [29]. The recovery of TEAOH is 
low compared to other EAs. At a low concentration level (5 ng/mL), the 
recovery for TEAOH reached 50%, and it might be contributed from the 
background effect from urine and LC eluents. For EDEA and MDEA, the 
recoveries were more than 85% at all levels. 
4. Conclusion 
This method was fully validated using silica SPE cartridge and PGC 
column for EAs analysis in the urine sample. It was linear and precise 
from 5 to 500, 5 to 250, and 0.5 to 500 ng/mL for TEAOH, EDEA, and 
MDEA, respectively. The method LOQ using this approach was 0.4, 5.5, 
and 6.3 ng/mL for MDEA, EDEA and TEAOH, respectively. In addition, a 
lower sample volume was used, and several urine samples can be treated 
simultaneously using silica SPE cartridges. The optimisation of the SPE 
procedures also increased the recovery of the highly hydrophilic EAs 
from urine samples. For LC-MS/MS method, the combination of PGC 
column and higher pH LC eluents successfully retained EAs and chro-
matographically separated them. Less than 10 min is required per 
sample for the instrument analysis. This method can also be applied to 
water samples. 
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Fig. 5. An average of calibration curves (n = 9) for TEAOH.  
Table 4 
Method LOD and LOQ for EAs determined from calibration curves (ng/mL).  
Chemicals LOD LOQ 
TEAOH 1.9 6.3 
EDEA 1.7 5.5 
MDEA 0.1 0.4  
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The recovery results for TEAOH, EDEA and MDEA. Standard deviation (SD), 
relative standard deviation (RSD) (n = 3).  






TEAOH 5 50 2.2 4.4 
50 34 0.4 1.3 
250 35 0.4 1.3 
EDEA 5 86 6.5 7.5  
50 89 2.8 3.1  
250 91 1.3 1.5 
MDEA 5 89 1.6 1.8  
50 88 1.2 1.3  
250 95 0.6 0.7  
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